906 related articles for article (PubMed ID: 7484583)
1. Diagnosis of renal artery stenosis: feasibility of combining MR angiography, MR renography, and gadopentetate-based measurements of glomerular filtration rate.
Ros PR; Gauger J; Stoupis C; Burton SS; Mao J; Wilcox C; Rosenberg EB; Briggs RW
AJR Am J Roentgenol; 1995 Dec; 165(6):1447-51. PubMed ID: 7484583
[TBL] [Abstract][Full Text] [Related]
2. Contrast-enhanced MR angiography for the diagnosis of intracranial vascular disease: optimal dose of gadopentetate dimeglumine.
Jung HW; Chang KH; Choi DS; Han MH; Han MC
AJR Am J Roentgenol; 1995 Nov; 165(5):1251-5. PubMed ID: 7572513
[TBL] [Abstract][Full Text] [Related]
3. Gadopentetate dimeglumine as a marker of renal function. Magnetic resonance imaging to glomerular filtration rates.
Frank JA; Choyke PL; Austin HA; Girton ME; Weiss G
Invest Radiol; 1991 Nov; 26 Suppl 1():S134-6; discussion S137-8. PubMed ID: 1808110
[No Abstract] [Full Text] [Related]
4. Diagnosis of renovascular hypertension: feasibility of captopril-sensitized dynamic MR imaging and comparison with captopril scintigraphy.
Grenier N; Trillaud H; Combe C; Degrèze P; Jeandot R; Gosse P; Douws C; Palussière J
AJR Am J Roentgenol; 1996 Apr; 166(4):835-43. PubMed ID: 8610560
[TBL] [Abstract][Full Text] [Related]
5. MR arthrography of the shoulder with gadopentetate dimeglumine: influence of concentration, iodinated contrast material, and time on signal intensity.
Kopka L; Funke M; Fischer U; Keating D; Oestmann J; Grabbe E
AJR Am J Roentgenol; 1994 Sep; 163(3):621-3. PubMed ID: 8079856
[TBL] [Abstract][Full Text] [Related]
6. Renal time-resolved MR angiography: quantitative comparison of gadobenate dimeglumine and gadopentetate dimeglumine with different doses.
Völk M; Strotzer M; Lenhart M; Seitz J; Manke C; Feuerbach S; Link J
Radiology; 2001 Aug; 220(2):484-8. PubMed ID: 11477257
[TBL] [Abstract][Full Text] [Related]
7. Dynamic three-dimensional MR renography for the measurement of single kidney function: initial experience.
Lee VS; Rusinek H; Noz ME; Lee P; Raghavan M; Kramer EL
Radiology; 2003 Apr; 227(1):289-94. PubMed ID: 12615998
[TBL] [Abstract][Full Text] [Related]
8. Arterial-phase three-dimensional contrast-enhanced MR angiography of the carotid arteries.
Levy RA; Prince MR
AJR Am J Roentgenol; 1996 Jul; 167(1):211-5. PubMed ID: 8659374
[TBL] [Abstract][Full Text] [Related]
9. Suppression of venous signal in time-of-flight MR angiography of the lower extremities after administration of gadopentetate dimeglumine.
Rofsky NM; Purdy DE; Johnson G; DeCorato DR; Earls JP; Krinsky G; Weinreb JC
Radiology; 1997 Jan; 202(1):177-82. PubMed ID: 8988209
[TBL] [Abstract][Full Text] [Related]
10. Asymmetric signal intensity of the renal collecting systems as a sign of unilateral renal artery stenosis following administration of gadopentetate dimeglumine.
Walsh P; Rofsky NM; Krinsky GA; Weinreb JC
J Comput Assist Tomogr; 1996; 20(5):812-4. PubMed ID: 8797919
[No Abstract] [Full Text] [Related]
11. MR renography using a dynamic gradient-echo sequence and low-dose gadopentetate dimeglumine as an alternative to radionuclide renography.
Teh HS; Ang ES; Wong WC; Tan SB; Tan AG; Chng SM; Lin MB; Goh JS
AJR Am J Roentgenol; 2003 Aug; 181(2):441-50. PubMed ID: 12876024
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance renography: optimisation of pulse sequence parameters and Gd-DTPA dose, and comparison with radionuclide renography.
Taylor J; Summers PE; Keevil SF; Saks AM; Diskin J; Hilton PJ; Ayers AB
Magn Reson Imaging; 1997; 15(6):637-49. PubMed ID: 9285803
[TBL] [Abstract][Full Text] [Related]
13. Differentiating between T1 and T2* changes caused by gadopentetate dimeglumine in the kidney by using a double-echo dynamic MR imaging sequence.
Kuperman VY; Karczmar GS; Blomley MJ; Lewis MZ; Lubich LM; Lipton MJ
J Magn Reson Imaging; 1996; 6(5):764-8. PubMed ID: 8890014
[TBL] [Abstract][Full Text] [Related]
14. Contrast-enhanced MR Angiography of the renal arteries: blinded multicenter crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine.
Prokop M; Schneider G; Vanzulli A; Goyen M; Ruehm SG; Douek P; Daprà M; Pirovano G; Kirchin MA; Spinazzi A
Radiology; 2005 Feb; 234(2):399-408. PubMed ID: 15616119
[TBL] [Abstract][Full Text] [Related]
15. Effect of the rate of gadopentetate dimeglumine administration on abdominal vascular and soft-tissue MR imaging enhancement patterns.
Strouse PJ; Prince MR; Chenevert TL
Radiology; 1996 Dec; 201(3):809-16. PubMed ID: 8939236
[TBL] [Abstract][Full Text] [Related]
16. Gadobenate dimeglumine (MultiHance) in MR angiography: an in-vitro phantom comparison with gadopentetate dimeglumine (Magnevist) at different concentrations.
Johansson L; Kirchin MA; Ahlström H
Acta Radiol; 2012 Dec; 53(10):1112-7. PubMed ID: 23081961
[TBL] [Abstract][Full Text] [Related]
17. Azotemia: gadopentetate dimeglumine as contrast agent at digital subtraction angiography.
Matchett WJ; McFarland DR; Russell DK; Sailors DM; Moursi MM
Radiology; 1996 Nov; 201(2):569-71. PubMed ID: 8888260
[TBL] [Abstract][Full Text] [Related]
18. Peripheral vascular disease evaluated with reduced-dose gadolinium-enhanced MR angiography.
Rofsky NM; Johnson G; Adelman MA; Rosen RJ; Krinsky GA; Weinreb JC
Radiology; 1997 Oct; 205(1):163-9. PubMed ID: 9314979
[TBL] [Abstract][Full Text] [Related]
19. Chemical shift misregistration artifact: increased conspicuity following intravenous administration of gadopentetate dimeglumine.
Apicella PL; Mirowitz SA; Borrello JA
Magn Reson Imaging; 1994; 12(4):675-8. PubMed ID: 8057773
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of renal artery stenosis with dynamic gadolinium-enhanced MR angiography.
Rieumont MJ; Kaufman JA; Geller SC; Yucel EK; Cambria RP; Fang LS; Bazari H; Waltman AC
AJR Am J Roentgenol; 1997 Jul; 169(1):39-44. PubMed ID: 9207498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
